Borgeson Blake

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
57
Insider Sells Sum
$7.64M

Insider Activity of Borgeson Blake

According to the SEC Form 4 filings, Borgeson Blake, being in a position of

  1. director at Recursion Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 350185 shares for $3.19M,
    over all time since 2021-11-18, has bought 0 shares, and sold 763479 shares for $7.64M.

The largest sale of all time was on 2022-11-16 and amounted to 35540 shares of Recursion Pharmaceuticals, Inc. for $395,219.

Biography of Borgeson Blake

No biography is available at this moment.

2024-10-01SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0035%
$6.22$71,150-0.97%
2024-09-17SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0042%
$6.84$78,333-1.92%
2024-09-03SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0043%
$6.27$71,718+7.08%
2024-08-20SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0041%
$7.12$81,532-6.98%
2024-08-06SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0045%
$6.82$78,083-0.97%
2024-07-23SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0043%
$8.48$97,0410%
2024-07-09SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0042%
$7.32$83,7350%
2024-06-25SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.005%
$9.51$108,806-26.33%
2024-06-11SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0049%
$8.45$96,763-16.61%
2024-05-28SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0051%
$9.17$104,943-17.8%
2024-05-14SaleRecursion Pharmaceuticals, Inc.
RXRX
director
20,054
0.0088%
$10.12$202,934-22.29%
2024-04-30SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0051%
$7.95$90,964+4.73%
2024-04-16SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0054%
$7.66$87,725+5.03%
2024-04-02SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.0053%
$8.82$100,942-7.18%
2024-03-19SaleRecursion Pharmaceuticals, Inc.
RXRX
director
20,054
0.0093%
$10.79$216,423-22.42%
2024-03-05SaleRecursion Pharmaceuticals, Inc.
RXRX
director
20,054
0.0097%
$12.06$241,805-28.25%
2024-02-20SaleRecursion Pharmaceuticals, Inc.
RXRX
director
20,054
0.0094%
$12.32$247,125-31.73%
2024-02-06SaleRecursion Pharmaceuticals, Inc.
RXRX
director
11,447
0.005%
$9.30$106,489-7.91%
2024-01-23SaleRecursion Pharmaceuticals, Inc.
RXRX
director
20,054
0.0093%
$10.58$212,083-16.76%
2024-01-09SaleRecursion Pharmaceuticals, Inc.
RXRX
director
20,054
0.0094%
$13.62$273,202-33.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.